LOVE.TO CANNARA BIOTECH INC
$1.99▲ +1.53%
Healthcare
Other
Volume 9.6K
Avg Volume (10D) 31.2K
Key Metrics & Fundamentals
Market Cap
$196.58M
P/E Ratio
18.1
Div Yield
–%
52W Range
1.55 - 2.07
% vs 50 MA
1.82%
% vs 200 MA
7.97%
RSI-14
48.9
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.03
Free Cash Flow
$1.28M
Gross Rev
$31.83M
Gross Profit
$15.03M
EBITDA
$9.02M
COGS
$16.80M
Operating Exp
$7.67M
Operating Income
$7.36M
EBIT
$7.36M
Pretax Income
$6.87M
Net Income
$4.84M
EPS (Diluted)
0.05
Price & Volume History
Loading chart…
Recent News

Cannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued Growth
GlobeNewswire · Sep 10, 2026 12:00 PM

3 Canadian Penny Stocks To Own In September 2026
Simply Wall St. · Sep 6, 2026 2:10 PM
Cannara Biotech Appoints Nicholas Fozard as CFO
MT Newswires · Sep 1, 2026 1:00 PM

Cannara Appoints Nicholas Fozard as Chief Financial Officer
GlobeNewswire · Sep 1, 2026 12:00 PM

3 Canadian Penny Stocks Backing Growth With Buybacks and Positive Earnings
Simply Wall St. · Aug 26, 2026 10:16 AM

Cannara Establishes Automatic Share Purchase Plan
GlobeNewswire · Aug 13, 2026 12:00 PM
Cannara Biotech to Begin a Normal Course Issuer Bid
MT Newswires · Jul 22, 2026 12:58 PM
Cannara Announces Normal Course Issuer Bid
GlobeNewswire · Jul 22, 2026 12:00 PM
Cannara Biotech Price Target Raised to C$4 at TD
MT Newswires · Jul 16, 2026 12:10 PM
Cannara Biotech Inc (LOVFF) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com · Jul 15, 2026 11:00 PM
Financial Overview - Income Statement
Quarterly
May 2026
See LOVE.TO's money flow as a full page
Social Sentiment
No Reddit posts found for LOVE.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.